More consistent antilipolitic and antiketogenetic action of insulin Glargine U300 vs U100 in type 1 diabetes

被引：0
|
作者：
Lucidi, P. [1 ]
Candeloro, P. [1 ]
Andreoli, A. Marinelli [1 ]
Cioli, P. [1 ]
Bolli, G. B. [1 ]
Fanelli, C. G. [1 ]
Porcellati, F. [1 ]
机构：
[1] Univ Perugia, Internal Med, Perugia, Italy
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
673
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [1] More Consistent Antilipolitic and Antiketogenetic Action of Insulin Glargine U300 vs. U100 in Type 1 Diabetes
    Lucidi, Paola
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Cioli, Patrizia
    Bolli, Geremia B.
    Fanelli, Carmine G.
    Porcellati, Francesca
    [J]. DIABETES, 2017, 66 : A270 - A270
  • [2] More physiological circulating insulin and modulation of hepatic glucose production with insulin Glargine U300 vs U100 in type 1 diabetes
    Porcellati, F.
    Lucidi, P.
    Andreoli, A. Marinelli
    Cioli, P.
    Candeloro, P.
    Bolli, G. B.
    Fanelli, C. G.
    [J]. DIABETOLOGIA, 2017, 60 : S307 - S308
  • [3] More Physiological Circulating Insulin and Modulation of Hepatic Glucose Production with Insulin Glargine U300 vs. U100 in Type 1 Diabetes
    Porcellati, Francesca
    Lucidi, Paola
    Andreoli, Anna Marinelli
    Cioli, Patrizia
    Candeloro, Paola
    Bolli, Geremia B.
    Fanelli, Carmine G.
    [J]. DIABETES, 2017, 66 : A269 - A269
  • [4] Greater Suppression of Glucagon, Lipolysis, and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus
    Lucidi, Paola
    Porcellati, Francesca
    Cioli, Patrizia
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 (01) : 57 - 61
  • [5] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Urrutia, M. Agustina
    Cardona, Saumeth
    Albury, Bonnie
    Galindo, Rodolfo J.
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES CARE, 2020, 43 (06) : 1242 - 1248
  • [6] A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients with Type 2 Diabetes: Glargine U300 Hospital Trial
    Pasquel, Francisco J.
    Lansang, M. Cecilia
    Khowaja, Ameer
    Galindo, Rodolfo J.
    Urrutia, Maria A.
    Cardona, Saumeth
    Shakally, Almoutaz
    Lyerla, Ryan C.
    Anzola, Isabel
    Albury, Bonnie S.
    Haw, J. Sonya
    Fayfman, Maya
    Davis, Georgia
    Migdal, Alexandra
    Vellanki, Priyathama
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES, 2019, 68
  • [7] Effectiveness and Safety of the Insulin Degludec U100 vs. Glargine U300 in People with Type 1 diabetes-The IneoxPlus Real-World Study
    De Adana, Maria S. Ruiz, Sr.
    Dominguez-Lopez, Marta E.
    Mora, Maria Del Rosario Vallejo
    Colomo, Natalia
    Linares, Francisca
    Morillas, Virginia
    Herrera, Maria Jose Vallejo
    Gallardo, Silvia Patricia Alonso
    Fuentes, Maria Teresa Padilla
    Vela, Luis I. Navas
    Maldonado-Araque, Cristina
    Olveira, Gabriel
    Martinez, Gemma Rojo
    [J]. DIABETES, 2023, 72
  • [8] Dosage profile of insulin glargine U100 and U300 in patients with type 2 diabetes in real clinical practice: DosInGlar study
    Duque, N.
    Artime, E.
    Romera, I.
    Lebrec, J.
    Diaz, S.
    Sicras, A.
    Reviriego, J.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S320 - S320
  • [9] Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes
    Porcellati, Francesca
    Lucidi, Paola
    Candeloro, Paola
    Cioli, Patrizia
    Andreoli, Anna Marinelli
    Curti, Gianluca
    Bolli, Geremia B.
    Fanelli, Carmine G.
    [J]. DIABETES CARE, 2019, 42 (01) : 85 - 92
  • [10] Euglycemic Clamp Profile of New Insulin Glargine U300 Formulation in Patients With Type 1 Diabetes (T1DM) Is Different from Glargine U100
    Tillner, Joachim
    Bergmann, Karin
    Teichert, Lenore
    Dahmen, Raphael
    Heise, Tim
    Becker, Reinhard H. A.
    [J]. DIABETES, 2013, 62 : A234 - A234
12345